Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Sex differences in autoimmune disease.
Demyelination of the hippocampus is prominent in the cuprizone model.
FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination.
Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study.
Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS.
Origin, fate and dynamics of macrophages at central nervous system interfaces.
Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.
HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica.
Cost-Effectiveness of Treatments for Relapsing Remitting Multiple Sclerosis: A French Societal Perspective.
Effects of dimethyl fumarate on neuroprotection and immunomodulation.
Quantifying the early stages of remyelination following cuprizone-induced demyelination.
TECFIDERA prescribing information
Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders.
Sex differences in autoimmune diseases.
Teva Receives Positive Outcome in Europe for Three-Times-a-Week COPAXONE® (Glatiramer Acetate) 40 mg/ml for the Treatment of Relapsing Forms of Multiple Sclerosis (RMS)
The neuroendocrine axis in patients with multiple sclerosis.
IL-2Rβγ-signaling contributes to regulatory T cell maintenance and stability in daclizumab HYP-treated RRMS patients
Optical coherence tomography reflects brain atrophy in MS: A four year study.
Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response.
Oral BG-12 (dimethyl fumarate) significantly reduced multiple sclerosis (MS) relapses and disability progression in DEFINE Phase 3 clinical trial
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
Inhibition of LINGO-1 promotes functional recovery after experimental spinal cord demyelination.
Biogen Idec to acquire Fumapharm AG; Consolidates ownership of oral compound BG-12 being studied for multiple sclerosis
TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.

Pages